Papers/PMID:16856053
Potassium supplementation for the management of primary hypertension in adults.
The Cochrane database of systematic reviews2006The record
2 findings · 1 compound · 2 endpoints · 2 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
2 findings
K(+) — no detected effect on systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Meta-analysis of five trials (n=425) with adequate data indicated that potassium supplementation compared to control resulted in a large but statistically non-significant reductions in SBP (mean difference: -11.2, 95% CI: -25.2 to 2.7) and DBP (mean difference: -5.0, 95% CI: -12.5 to 2.4).”
Quoted verbatim from Potassium supplementation for the management of primary hypertension in adults.. - Study
- meta-analysis
- Participants
- 425
- Population
- Adults with raised blood pressure (SBP >=140 or DBP >=85 mmHg), five trials with adequate data, 8 to 16 weeks follow-up
Effect -11.2 mean difference, 95% CI -25.2 to 2.7
Potassium supplementation for the management of primary hypertension in adults.2006PMID:16856053Permalink
K(+) — no detected effect on diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Meta-analysis of five trials (n=425) with adequate data indicated that potassium supplementation compared to control resulted in a large but statistically non-significant reductions in SBP (mean difference: -11.2, 95% CI: -25.2 to 2.7) and DBP (mean difference: -5.0, 95% CI: -12.5 to 2.4).”
Quoted verbatim from Potassium supplementation for the management of primary hypertension in adults.. - Study
- meta-analysis
- Participants
- 425
- Population
- Adults with raised blood pressure (SBP >=140 or DBP >=85 mmHg), five trials with adequate data, 8 to 16 weeks follow-up
Effect -5 mean difference, 95% CI -12.5 to 2.4
Potassium supplementation for the management of primary hypertension in adults.2006PMID:16856053Permalink